Pharmaceuticals for Women’s Health: Global Markets to 2023 - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--Jul 11, 2018--The “Pharmaceuticals for Women’s Health: Global Markets to 2023” report has been added to ResearchAndMarkets.com’s offering. While women’s health encompasses several health issues, this report will focus on menopause-related disorders, postmenopausal osteoporosis, endometriosis, polycystic ovarian syndrome and pregnancy disorders. Report includes:Detailed overview of the global markets for pharmaceuticals for women’s health Country specific data and analysis for United States, Mexico, Germany, U.K., France, China, India, Japan, Middle East and Africa A look at the regulatory environment which has been a driving force in the drug development industry Information on competitor initiatives, and information with regard to demand for specialty chemicals used to develop new products and for new applications A relevant patent analysis within the sector Comprehensive company profiles of major Players in the Market including AbbVie Inc., Allergan PLC, Amgen Inc., Bayer Ag., Eli Lilly and Company, Johnson & Johnson Inc., Novo Nordisk and Pfizer Inc.
Companies FeaturedAbbvie Inc. Allergan Plc. Amgen Inc. Bayer AG Daiichi Sankyo Company. Ltd. Eli Lilly And Company Johnson & Johnson Inc. Merck & Co. Inc. Merck KGaA Novo Nordisk Pfizer Inc.
Key Topics Covered Chapter 1 Introduction Chapter 2 Summary and Highlights Chapter 3 Technologies and Global Markets Overview Chapter 4 Pipeline Assessment and Analysis Chapter 5 Regulatory Structure Chapter 6 Market Breakdown by Women’s Health Disorders Chapter 7 Market Breakdown by Region Chapter 8 Competitive Landscape and Key Developments Chapter 9 Company Profiles Chapter 10 Appendix For more information about this report visit https://www.researchandmarkets.com/research/tgxdzm/pharmaceuticals?w=4
View source version on businesswire.com:https://www.businesswire.com/news/home/20180711005408/en/
Laura Wood, Senior Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics:Women’s Health
INDUSTRY KEYWORD: WOMEN HEALTH PHARMACEUTICAL CONSUMER
SOURCE: Research and Markets
Copyright Business Wire 2018.
PUB: 07/11/2018 07:44 AM/DISC: 07/11/2018 07:44 AM